Rat model of familial combined hyperlipidemia as a result of comparative mapping

Physiological Genomics

Volumn 17, Issue , 2004, Pages 38-47

  Ueno, Takahiro ^a   Tremblay, Johanne ^a   Kunes, Jaroslav ^b   Zicha, Josef ^b   Dobesova, Zdenka ^b   Pausova, Zdenka ^a   Deng, Alan Y ^a   Sun, Yu Lin ^a   Jacob, Howard J ^c   Hamet, Pavel ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b INSTITUTE OF PHYSIOLOGY   (Czech Republic)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Cholesterol; Metabolic syndrome; Prague hypertriglyceridemic rat; Quantitative trait locus; Triglycerides

Indexed keywords

ANIMAL MODEL; ARTICLE; CHROMOSOME 1; CHROMOSOME 13; CHROMOSOME 2; COMPARATIVE GENE MAPPING; FAMILIAL COMBINED HYPERLIPIDEMIA; FAMILIAL HYPERLIPEMIA; FEMALE; GENE LOCUS; GENETIC LINKAGE; GENOME; HEREDITY; HYPERTRIGLYCERIDEMIA; MALE; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS MAPPING; RAT; SYNTENY; ANIMAL; BLOOD; CHROMOSOME MAP; COMPARATIVE STUDY; DISEASE MODEL; GENETIC MARKER; GENETIC SCREENING; GENETICS; HUMAN; LEWIS RAT; METHODOLOGY; PATHOLOGY; QUANTITATIVE TRAIT LOCUS; SEXUAL DEVELOPMENT; WISTAR RAT;

ANIMALIA;

CHOLESTEROL; TRIACYLGLYCEROL;

ANIMALS; CHOLESTEROL; CHROMOSOME MAPPING; DISEASE MODELS, ANIMAL; FEMALE; GENETIC MARKERS; GENETIC SCREENING; GENOME; HUMANS; HYPERLIPIDEMIA, FAMILIAL COMBINED; LINKAGE (GENETICS); MALE; PHENOTYPE; QUANTITATIVE TRAIT LOCI; RATS; RATS, INBRED LEW; RATS, WISTAR; SEX CHARACTERISTICS; TRIGLYCERIDES;

EID: 3142734395     PISSN: 15312267     EISSN: None     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00043.2003     Document Type: Article

References (65)

1. Aitman TJ, Glazier AM, Wallace CA, Cooper LD, Norsworthy PJ, Wahid FN, al Majali KM, Trembling PM, Mann CJ, Shoulders CC, Graf D, St Lezin E, Kurtz TW, Kren V, Pravenec M, Ibrahimi A, Abumrad NA, Stanton LW, and Scott J. Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats. Nat Genet 21: 76-83, 1999.
2. Aitman TJ, Godsland IF, Farren B, Crook D, Wong HJ, and Scott J. Defects of insulin action on fatty acid and carbohydrate metabolism in familial combined hyperlipidemia. Arterioscler Thromb Vasc Biol 17: 748-754, 1997.
3. Almasy L and Blangero J. Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet 62: 1198-1211, 1998.
4. Aouizerat BE, Allayee H, Bodnar J, Krass KL, Peltonen L, de Bruin TW, Rotter JI, and Lusis AJ. Novel genes for familial combined hyperlipidemia. Curr Opin Lipidol 10: 113-122, 1999.
5. Aouizerat BE, Allayee H, Cantor RM, Davis RC, Lanning CD, Wen PZ, Dallinga-Thie GM, de Bruin TW, Rotter JI, and Lusis AJ. A genome scan for familial combined hyperlipidemia reveals evidence of linkage with a locus on chromosome 11. Am J Hum Genet 65: 397-412, 1999.
6. Austin MA, Brunzell JD, Fitch WL, and Krauss RM. Inheritance of low density lipoprotein subclass patterns in familial combined hyperlipidemia. Arteriosclerosis 10: 520-530, 1990.
7. Babirak SP, Brown BG, and Brunzell JD. Familial combined hyperlipidemia and abnormal lipoprotein lipase. Arterioscler Thromb 12: 1176-1183, 1992.
8. Castellani LW, Weinreb A, Bodnar J, Goto AM, Doolittle M, Mehrabian M, Demant P, and Lusis AJ. Mapping a gene for combined hyperlipidaemia in a mutant mouse strain. Nat Genet 18: 374-377, 1998.
9. Chvojkova S, Kazdova L, and Divisova JA. A comparison of the effects of troglitazone and vitamin E on the fatty acid composition of serum phospholipids in an experimental model of insulin resistance. Physiol Res 50: 261-266, 2001.
10. Coon H, Myers RH, Borecki IB, Arnett DK, Hunt SC, Province MA, Djousse L, and Leppert MF. Replication of linkage of familial combined hyperlipidemia to chromosome 1q with additional heterogeneous effect of apolipoprotein A-I/C-III/A-IV locus. The NHLBI Family Heart Study. Arterioscler Thromb Vasc Biol 20: 2275-2280, 2000.
11. Darvasi A. The effect of selective genotyping on QTL mapping accuracy. Mamm Genome 8: 67-68, 1997.
12. Darvasi A and Soller M. Selective genotyping for determination of linkage between a marker locus and a quantitative trait locus. Theor Appl Genet 85: 353-359, 1992.
13. Darvasi A and Soller M. Advanced intercross lines, an experimental population for fine genetic mapping. Genetics 141: 1199-1207, 1995.
14. de Roos B, Caslake MJ, Ardern HA, Martin BG, Suckling KE, and Packard CJ. Insulin resistance in the St. Thomas' mixed hyperlipidaemic (SMHL) rabbit, a model for familial combined hyperlipidaemia. Atherosclerosis 156: 249-254, 2001.
15. Delawi D, Meijssen S, and Castro CM. Intra-individual variations of fasting plasma lipids, apolipoproteins and postprandial lipemia in familial combined hyperlipidemia compared to controls. Clin Chim Acta 328: 139-145, 2003.
16. Deng AY, Dene H, Pravenec M, and Rapp JP. Genetic mapping of two new blood pressure quantitative trait loci in the rat by genotyping endothelin system genes. J Clin Invest 93: 2701-2709, 1994.
17. Ferrannini E. Syndrome X. Horm Res 39, Suppl 3: 107-111, 1993.
18. Glueck SB and Dzau VJ. Physiological genomics: implications in hypertension research. Hypertension 39: 310-315, 2002.
19. Goldstein JL, Schrott HG, Hazzard WR, Bierman EL, and Motulsky AG. Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J. Clin Invest 52: 1544-1568, 1973.
20. Grundy SM. United States Cholesterol Guidelines 2001: expanded scope of intensive low-density lipoprotein-lowering therapy. Am J Cardiol 88: 23J-27J, 2001.
21. Hamet P. Apolipoprotein E alleles and hypertension: controversy or lack of understanding? J Hypertens 20: 1941-1942, 2002.
22. Hamet P, Pausova Z, Adarichev S, Adaricheva K, and Tremblay J. Hypertension: genes and environment. J Hypertens 16: 397-418, 1998.
23. Hokanson JE, Austin MA, Zambon A, and Brunzell JD. Plasma triglyceride and LDL heterogeneity in familial combined hyperlipidemia. Arterioscler Thromb 13: 427-434, 1993.
24. Hokanson JE, Krauss RM, Albers JJ, Austin MA, and Brunzell JD. LDL physical and chemical properties in familial combined hyperlipidemia. Arterioscler Thromb Vasc Biol 15: 452-459, 1995.
25. Keulen ET, Voors-Pette C, and de Bruin TW. Familial dyslipidemic hypertension syndrome: familial combined hyperlipidemia, and the role of abdominal fat mass. Am J Hypertens 14: 357-363, 2001.
26. Kissebah AH, Sonnenberg GE, Myklebust J, Goldstein M, Broman K, James RG, Marks JA, Krakower GR, Jacob HJ, Weber J, Martin L, Blangero J, and Comuzzie AG. Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome. Proc Natl Acad Sci USA 97: 14478-14483, 2000.
27. Kloting I, Kovacs P, and van den Brandt J. Sex-specific and sex-independent quantitative trait loci for facets of the metabolic syndrome in WOKW rats. Biochem Biophys Res Commun 284: 150-156, 2001.
28. Kovacs P and Kloting I. Quantitative trait loci on chromosomes 1 and 4 affect lipid phenotypes in the rat. Arch Biochem Biophys 354: 139-143, 1998.
29. Kovacs P, van den Brandt J, and Kloting I. Effects of quantitative trait loci for lipid phenotypes in the rat are influenced by age. Clin Exp Pharmacol Physiol 25: 1004-1007, 1998.
30. Kovacs P, van den Brandt J, and Kloting I. Genetic dissection of the syndrome X in the rat. Biochem Biophys Res Commun 269: 660-665, 2000.
31. Kunes J, Dobesova Z, and Zicha J. Altered balance of main vasopressor and vasodepressor systems in rats with genetic hypertension and hypertriglyceridaemia. Clin Sci (Lond) 102: 269-277, 2002.
32. Kwitek-Black AE and Jacob HJ. The use of designer rats in the genetic dissection of hypertension. Curr Hypertens Rep 3: 12-18, 2001.
33. Lefebvre AM, Peinado-Onsurbe J, Leitersdorf I, Briggs MR, Paterniti JR, Fruchart JC, Fievet C, Auwerx J, and Staels B. Regulation of lipoprotein metabolism by thiazolidinediones occurs through a distinct but complementary mechanism relative to fibrates. Arterioscler Thromb Vasc Biol 17: 1756-1764, 1997.
34. Manly KF and Olson JM. Overview of QTL mapping software and introduction to Map Manager QT. Mamm Genome 10: 327-334, 1999.
35. Masucci-Magoulas L, Goldberg IJ, Bisgaier CL, Serajuddin H, Francone OL, Breslow JL, and Tall AR. A mouse model with features of familial combined hyperlipidemia. Science 275: 391-394, 1997.
36. Nikkila EA and Aro A. Family study of serum lipids and lipoproteins in coronary heart-disease. Lancet 1: 954-959, 1973.
37. Pajukanta P, Bodnar JS, Sallinen R, Chu M, Airaksinen T, Xiao Q, Castellani LW, Sheth SS, Wessman M, Palotie A, Sinsheimer JS, Demant P, Lusis AJ, and Peltonen L. Fine mapping of Hyplip1 and the human homolog, a potential locus for FCHL. Mamm Genome 12: 238-245, 2001.
38. Pajukanta P, Nuotio I, Terwilliger JD, Porkka KV, Ylitalo K, Pihlajamaki J, Suomalainen AJ, Syvanen AC, Lehtimaki T, Viikari JS, Laakso M, Taskinen MR, Ehnholm C, and Peltonen L. Linkage of familial combined hyperlipidaemia to chromosome 1q21-q23. Nat Genet 18: 369-373, 1998.
39. Pajukanta P, Terwilliger JD, Perola M, Hiekkalinna T, Nuotio I, Ellonen P, Parkkonen M, Hartiala J, Ylitalo K, Pihlajamaki J, Porkka K, Laakso M, Viikari J, Ehnholm C, Taskinen MR, and Peltonen L. Genomewide scan for familial combined hyperlipidemia genes in Finnish families, suggesting multiple susceptibility loci influencing triglyceride, cholesterol, and apolipoprotein B levels. Am J Hum Genet 64: 1453-1463, 1999.
40. Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, and Heymsfield SB. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 163: 427-436, 2003.
41. Pausova Z, Tremblay J, and Hamet P. Gene-environment interactions in hypertension. Curr Hypertens Rep 1: 42-50, 1999.
42. Pei W, Baron H, Muller-Myhsok B, Knoblauch H, Al Yahyaee SA, Hui R, Wu X, Liu L, Busjahn A, Luft FC, and Schuster H. Support for linkage of familial combined hyperlipidemia to chromosome 1q21-q23 in Chinese and German families. Clin Genet 57: 29-34, 2000.
43. Pihlajamaki J, Karjalainen L, Karhapaa P, Vauhkonen I, Taskinen MR, Deeb SS, and Laakso M. G-250A substitution in promoter of hepatic lipase gene is associated with dyslipidemia and insulin resistance in healthy control subjects and in members of families with familial combined hyperlipidemia. Arterioscler Thromb Vasc Biol 20: 1789-1795, 2000.
44. Pihlajamaki J, Miettinen R, Valve R, Karjalainen L, Mykkanen L, Kuusisto J, Deeb S, Auwerx J, and Laakso M. The Pro12A1a substitution in the peroxisome proliferator activated receptor gamma 2 is associated with an insulin-sensitive phenotype in families with familial combined hyperlipidemia and in nondiabetic elderly subjects with dyslipidemia. Atherosclerosis 151: 567-574, 2000.
45. Pihlajamaki J, Rissanen J, Heikkinen S, Karjalainen L, and Laakso M. Codon 54 polymorphism of the human intestinal fatty acid binding protein 2 gene is associated with dyslipidemias but not with insulin resistance in patients with familial combined hyperlipidemia. Arterioscler Thromb Vasc Biol 17: 1039-1044, 1997.
46. Pihlajamaki J, Rissanen J, Valve R, Heikkinen S, Karjalainen L, and Laakso M. Different regulation of free fatty acid levels and glucose oxidation by the Trp64Arg polymorphism of the beta3-adrenergic receptor gene and the promoter variant (A-3826G) of the uncoupling protein 1 gene in familial combined hyperlipidemia. Metabolism 47: 1397-1402, 1998.
47. Pihlajamaki J, Valve R, Karjalainen L, Karhapaa P, Vauhkonen I, and Laakso M. The hormone sensitive lipase gene in familial combined hyperlipidemia and insulin resistance. Eur J Clin Invest 31: 302-308, 2001.
48. Purnell JQ, Kahn SE, Schwartz RS, and Brunzell JD. Relationship of insulin sensitivity and ApoB levels to intra-abdominal fat in subjects with familial combined hyperlipidemia. Arterioscler Thromb Vasc Biol 21: 567-572, 2001.
49. Rainwater DL, Almasy L, Blangero J, Cole SA, VandeBerg JL, MacCluer JW, and Hixson JE. A genome search identifies major quantitative trait loci on human chromosomes 3 and 4 that influence cholesterol concentrations in small LDL particles. Arterioscler Thromb Vasc Biol 19: 777-783, 1999.
50. Reaven GM. Syndrome X. Blood Press Suppl 4: 13-16, 1992.
51. Reaven GM. Role of insulin resistance in human disease (syndrome X): an expanded definition. Annu Rev Med 44: 121-131, 1993.
52. Rose HG, Kranz P, Weinstock M, Juliano J, and Haft JI. Inheritance of combined hyperlipoproteinemia: evidence for a new lipoprotein phenotype. Am J Med 54: 148-160, 1973.
53. Shamir R, Tershakovec AM, Gallagher PR, Liacouras CA, Hayman LL, and Cortner JA. The influence of age and relative weight on the presentation of familial combined hyperlipidemia in childhood. Atherosclerosis 121: 85-91, 1996.
54. Stolba P, Dobesova Z, Husek P, Opltova H, Zicha J, Vrana A, and Kunes J. The hypertriglyceridemic rat as a genetic model of hypertension and diabetes. Life Sci 51: 733-740, 1992.
55. Stolba P, Opltova H, Husek P, Nedvidkova J, Kunes J, Dobesova Z, Nedvidek J, and Vrana A. Adrenergic overactivity and insulin resistance in nonobese hereditary hypertriglyceridemic rats. Ann NY Acad Sci 683: 281-288, 1993.
56. Stoll M, Cowley AW Jr, Tonellato PJ, Greene AS, Kaldunski ML, Roman RJ, Dumas P, Schork NJ, Wang Z, and Jacob HJ. A genomic-systems biology map for cardiovascular function. Science 294: 1723-1726, 2001.
57. Stoll M and Jacob HJ. Genetic rat models of hypertension: relationship to human hypertension. Curr Hypertens Rep 3: 157-164, 2001.
58. Ueno T, Tremblay J, Kunes J, Zicha J, Dobesova Z, Pausova Z, Deng AY, Sun YL, Jacob HJ, and Hamet P. Resolving the composite trait of hypertension into its pharmacogenetic determinants by acute pharmacological modulation of blood pressure regulatory systems. J Mol Med 81: 51-60, 2003.
59. Venkatesan S, Cullen P, Pacy P, Halliday D, and Scott J. Stable isotopes show a direct relation between VLDL apoB overproduction and serum triglyceride levels and indicate a metabolically and biochemically coherent basis for familial combined hyperlipidemia. Arterioscler Thromb 13: 1110-1118, 1993.
60. Vrana A and Kazdova L. The hereditary hypertriglyceridemic nonobese rat: an experimental model of human hypertriglyceridemia. Transplant Proc 22: 2579, 1990.
61. Vrana A, Kazdova L, Dobesova Z, Kunes J, Kren V, Bila V, Stolba P, and Klimes I. Triglyceridemia, glucoregulation, and blood pressure in various rat strains. Effects of dietary carbohydrates. Ann NY Acad Sci 683: 57-68, 1993.
62. Wijsman EM, Brunzell JD, Jarvik GP, Austin MA, Motulsky AG, and Deeb SS. Evidence against linkage of familial combined hyperlipidemia to the apolipoprotein AI-CIII-AIV gene complex. Arterioscler Thromb Vasc Biol 18: 215-226, 1998.
63. Wojciechowski AP, Farrall M, Cullen P, Wilson TM, Bayliss JD, Farren B, Griffin BA, Caslake MJ, Packard CJ, and Shepherd J. Familial combined hyperlipidaemia linked to the apolipoprotein AI-CII-AIV gene cluster on chromosome 11q23-q24. Nature 349: 161-164, 1991.
64. Xu CF, Talmud P, Schuster H, Houlston R, Miller G, and Humphries S. Association between genetic variation at the APO AI-CIII-AIV gene cluster and familial combined hyperlipidaemia. Clin Genet 46: 385-397, 1994.
65. Yang WS, Nevin DN, Iwasaki L, Peng R, Brown BG, Brunzell JD, and Deeb SS. Regulatory mutations in the human lipoprotein lipase gene in patients with familial combined hyperlipidemia and coronary artery disease. J Lipid Res 37: 2627-2637, 1996.